Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
5.16
+0.27 (5.52%)
Nov 4, 2024, 4:00 PM EST - Market closed
Kyverna Therapeutics Employees
Kyverna Therapeutics had 96 employees as of December 31, 2023.
Employees
96
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$790,792
Market Cap
222.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 834 |
| Lifecore Biomedical | 524 |
| Utah Medical Products | 190 |
| XBiotech | 82 |
| PepGen | 64 |
| Eton Pharmaceuticals | 30 |
| Trevi Therapeutics | 25 |
| Benitec Biopharma | 16 |
KYTX News
- 15 days ago - Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors - PRNewsWire
- 6 weeks ago - Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024 - PRNewsWire
- 7 weeks ago - Kyverna Therapeutics Announces Leadership Update - PRNewsWire
- 7 weeks ago - Kyverna Therapeutics, Inc. May Have Committed Securities Fraud And The Schall Law Firm Encourages Shareholders To Join An Inquiry - Accesswire
- 7 weeks ago - The Schall Law Firm Is Looking Into Whether Kyverna Therapeutics Inc Violated Securities Laws And Investors Are Invited To Participate - Accesswire
- 2 months ago - Shareholders With Losses In Kyverna Therapeutics, Inc. Should Contact The Schall Law Firm About A Securities Fraud Investigation - Accesswire
- 2 months ago - Kyverna Therapeutics Inc May Have Violated Securities Regulations And The Schall Law Firm Invites Investors To Join An Inquiry - Accesswire
- 2 months ago - Shareholders In Kyverna Therapeutics, Inc. Are Urged To Partake In The Schall Law Firm's Securities Related Investigation - Accesswire